Gyermekkori daganatok: vizsgálatok itt: Japán
48 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Chuo Ku, Kashiwa
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Chuo-ku, Kyoto, Nankoku, Sapporo, Tokyo, Yokohama
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 3. fázisTaking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Fukuoka, Ginowan-shi, Hidaka-shi, Kagoshima, Kōtoku, Kurume-shi, Maebashi, Matsuyama, Morioka, Nagoya, Osaka, Sapporo, Shinjuku-ku, Suita-shi, Sunto-gun, Toon-Shi
- Életkor
- 15 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Fukuoka, Saitama, Yokohama
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Bunkyo, Minato
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Kobe
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisTaking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Kanagawa, Okayama, Osaka, Shizuoka, Tokyo, Wakayama
- Életkor
- 12 év and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - 3. fázisTaking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Chiba, Chuo-ku, Fukuoka-shi, Fukuoka, Kanagawa, Kashiwa-shi, Matsuyama, Numakunai, Saitama, Sakaishi
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - No phaseTaking peopleA Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy
- Where
- Bunkyo Ku, Kurume, Osaka, Suita
- Életkor
- 15 év to 15 év
- People
- 30
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07378969 - 1/2. fázisTaking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Fukuoka, Fukushima, Kanazawa, Kashiwa, Kobe, Maebashi, Nagoya, Sapporo, Tokyo, Yamagata, Yoshida
- Életkor
- 2 év and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - 2/3. fázisTaking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Bunkyō City, Chiba, Chuo Ku, Fukuoka, Isehara City, Kanagawa, Kyoto, Minato-ku, Nagoya, Okayama, Osaka, Sapporo, Shibuya-ku, Shimotsuke, Shinjuku, Tennoji-Ku, Yamagata
- People
- 1541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bunkyō City, Kashiwa, Okayama
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Chiba, Ehime, Hiroshima, Hokkaido, Hyōgo, Kagoshima, Kanagawa, Kyoto, Mie, Nagoya, Osaka, Saitama, Shizuoka, Tōhoku, Tokyo
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 1/2. fázisTaking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Bunkyō City, Chūōku, Kashiwa
- Életkor
- 12 év and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - 2. fázisTaking peopleONO-4538 Phase II Rollover Study (ONO-4538-98)
- Where
- Akashi, Bunkyo-ku, Chiba, Chuo-ku, Fukuoka, Hidaka, Hiroshima, Kashiwa, Kitaadachi-gun, Koto-ku, Koto-Ku, Kurume, Kyoto, Matsuyama, Okayama, Osaka, Sapporo, Shinjuku-ku, Suita, Takatsuki, Yokohama, Yufu
- Életkor
- 16 év and over
- People
- 70 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT04566380 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Bunkyō City, Chiba, Chūōku, Fukuoka, Kashiwa, Kyoto, Okayama, Osaka, Sapporo, Toyohashi, Yamagata
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Bunkyō City, Kōtoku
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1/2. fázisTaking peopleA Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
- Where
- Chiba, Chuo Ku, Fukuoka, Hiroshima, Kanazawa, Kashiwa, Kyoto, Okayama, Osaka, Sakai, Sapporo, Sendai, Sunto-gun, Tsu, Yokohama
- Életkor
- 12 év and over
- People
- 50
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT07734116 - 1/2. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- Fukuoka, Hokkaido, Tokyo
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777 - 1/2. fázisTaking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Kanagawa, Okayama, Osaka, Shizuoka, Tokyo, Wakayama
- Életkor
- 12 év and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - 2. fázisCsak meghívásosLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Fukuoka, Kyoto, Okayama, Sapporo Hokkaido, Sendai, Tokyo
- People
- 1500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - No phaseTaking peopleAcute Ischemic Stroke in Patients With Active Cancer
- Where
- Suita
- People
- 500
- Run by
- Osaka University
See details and how to joinNCT07819526 - 3. fázisTaking peopleStudy of Out of Specification for Tisagenlecleucel
- Where
- Aomori, Bunkyo Ku, Chiba, Chuo Ku, Fuchū, Fukuoka, Gifu, Hamamatsu, Hiroshima, Ishikawa, Izumi, Izumisano, Izumo, Kita-gun, Kobe, Kumamoto, Kurashiki, Kyoto, Matsumoto, Minato Ku, Nagasaki, Nagoya, Niigata, Nishinomiya, Okayama, Osaka, Saitama, Sakai, Sapporo, Sendai, Setagaya-ku, Shinjuku Ku, Suita, Tōon, Tsu, Tsukuba, Wakayama, Yokohama, Yufu
- Életkor
- 0 év to 100 év
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04094311 - 3. fázisTaking peopleActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Chiba-sgi, Chuo-ku, Higashiku, Hiroshima, Kobe, Kyoto, Niigata, Nishinomiya, Hyogo, Osaka, Saitama, Sapporo, Sendai, Shinjuku-ku, Tokyo, Tsukuba, Yokohama
- People
- 1780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - 2. fázisTaking peopleA Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
- Where
- Chuo-Ku, Fukuoka, Kashiwa-shi, Kyoto, Nagoya, Okayama, Sapporo, Sendai
- Életkor
- 12 év and over
- People
- 100 worldwide
- Run by
- AbbVie
See details and how to joinNCT07196644 · EU 2024-518871-74-00